Showing results (2161-2170 of 3,022) with videos related to

Sort By:
Pageof 303
Hemasphere|March 4, 2024
Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R-ISS II patientsMaria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, et al.
Oncotarget|February 6, 2016
Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutationsDerya Aslan, Christian Garde, Mette Katrine Nygaard, et al.
European Heart Journal|November 26, 2009
Hyponatraemia: A strong predictor of mortality in adults with congenital heart diseaseKonstantinos Dimopoulos, Gerhard-Paul Diller, Ricardo Petraco, et al.
European Journal of Haematology|May 23, 2023
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapiesDespina Fotiou, Foteini Theodorakakou, Maria Gavriatopoulou, et al.
International Journal of Cancer|March 30, 2011
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2Apostolos C Ziogas, Nikos G Gavalas, Marinos Tsiatas, et al.
Southern Medical Journal|September 9, 2004
Does intraoperative electromyographic monitoring in lumbar microdiscectomy correlate with postoperative pain?Vassilios G Dimopoulos, Carlos H Feltes, Kostas N Fountas, et al.
Journal of the American College of Cardiology|September 19, 2006
Heart rate response during exercise predicts survival in adults with congenital heart diseaseGerhard-Paul Diller, Konstantinos Dimopoulos, Darlington Okonko, et al.
Circulation|September 19, 2007
Right ventricular mechanics and QRS duration in patients with repaired tetralogy of Fallot: implications of infundibular diseaseAnselm Uebing, Derek G Gibson, Sonya V Babu-Narayan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek Myeloma Study GroupK Zervas, D Mihou, E Katodritou, et al.
Pageof 303